Ryan Murray

Ryan Murray practices at G&S Medical Associates in Paterson, New Jersey.

Ryan Murray's NPI, 1003567397, was assigned on January 18, 2022. Ryan Murray holds New Jersey license 25MP00681400.

Ryan Murray's primary practice is G&S Medical Associates, at 606 Broadway, Paterson, NJ 07514 in Passaic County. The practice phone is (973) 523-1800.

Ryan Murray's primary practice is G&S Medical Associates in Paterson, New Jersey. Ryan Murray is also affiliated with St. Joseph's University Medical Center. The medical group on file is G&S Medical Associates. Dmand AI also links Ryan Murray to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ryan Murray practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ryan Murray's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Ryan Murray is licensed in New Jersey.

CMS data shows 115 Medicare services from Ryan Murray across 4 procedure codes in 2024, for 43 Medicare patients. Medicare paid $5,479 for them. Every service was in an office.

CMS counts 43 Medicare patients who saw Ryan Murray in 2024. The largest group is 65 to 74, with 24 patients. 63% of them have high cholesterol, and 56% have high blood pressure. 58% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Ryan Murray's median patient age at 46, with 60% women.

In 2024, Ryan Murray wrote 1,898 Medicare Part D claims for 184 patients. 86% of them were for generic drugs. CMS names the drug for 1,492 of them, across 52 drugs with 11 or more claims each, at $76,058 in total drug cost. In 2023, CMS named 1,766 claims across 55 drugs.

Ryan Murray accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ryan Murray as offering telehealth.

CMS Open Payments shows 48 general payments to Ryan Murray from 15 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $859.